A scientific consultant (diagnostics and patient finding) in the field of rare diseases and genetic disorders (Alnylam Pharmaceuticals, BioMarin Pharmaceuticals), with extensive experience in Biochemistry, Molecular biology, Genetics and Epigenetics, who is trained in research (Coventry University, Nottingham Trent University) and pathology (NHS and Public Health England) laboratories with a balance between industry, healthcare and academic skills. Adept at working methodically at high levels of competency in Enzymatic assays, DNA Methylation analysis, Immunoprecipitation, Cell Culture, Western blotting, Fluorescence based analysis, Gene Sequencing, Flow Cytometry, Confocal microscopy, FISH, qPCR, CRISPR-cas9 (including dCas9 for DNA Methylation) and numerous other molecular techniques to achieve the desired results in laboratory based project. Knowledge of Python (working knowledge of Keras, Tensorflow and supervised machine learning algorithms), HTML and Java.Key areas of expertise: Gene therapy, Artificial intelligence/Machine Learning, Precision Medicine, metabolic diseases, genetic diseases, biochemical testing and genetic testing.
Listed skills include Molecular Biology, Pcr, Cell Culture, Life Sciences, and 35 others.